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Abstract
Using MRSA isolates submitted to our hospital microbiology laboratory January 2001–March 2010 and the number of our
emergency department (ED) visits, quarterly community-associated (CA) and hospital-associated (HA) MRSA infections were
modeled using Poisson regressions. For pediatric patients, approximately 1.85x (95% CI 1.45x–2.36x, adj. p,0.0001) as many
CA-MRSA infections per ED visit occurred in the second two quarters as occurred in the first two quarters. For adult patients,
1.14x (95% CI 1.01x–1.29x, adj.p=0.03) as many infections per ED visit occurred in the second two quarters as in the first
two quarters. Approximately 2.94x (95% CI 1.39x–6.21x, adj.p=0.015) as many HA-MRSA infections per hospital admission
occurred in the second two quarters as occurred in the first two quarters for pediatric patients. No seasonal variation was
observed among adult HA-MRSA infections per hospital admission. We demonstrated seasonality of MRSA infections and
provide a summary table of similar observations in other studies.
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Introduction
Seasonal variation in Staphylococcus aureus infections is contro-
versial. Some studies have demonstrated a highly significant surge
of such infections during the warmest months and during autumn
in temperate and tropical settings [1–3]. However, a recent study
did not find such a correlation [4]. We have observed peaks of
community-associated methicillin-resistant S. aureus (CA-MRSA)
infections during the summer and autumn and we set out to
determine if there is a correlation between MRSA infections in
patients of all ages and seasonality.
Results
We found strong evidence of a seasonal effect in the rate of CA-
MRSA isolates per ED visit in both pediatric and adult patients
(Figure 1). For pediatric patients, a mean of approximately 1.85x
(95% CI 1.45x–2.36x, adj. p,0.0001) as many CA-MRSA
infections per ED visit occurred in the second two quarters as
occurred in the first two quarters over the study period. For adult
patients, the effect per number of ED visits was smaller
(adj.p=0.001), which indicated 1.14x (95% CI 1.01x–1.29x,
adj.p=0.03) as many infections per ED visit in the second two
quarters as in the first two quarters. Hospital-associated MRSA
(HA-MRSA) infections in pediatric patients had seasonal variation
(Figure 2). A mean of approximately 2.94x (95% CI 1.39x–6.21x,
adj.p=0.015) as many HA-MRSA infections per hospital
admission occurred in the second two quarters as occurred in
the first two quarters over the study period. This reflected greater
seasonal variation than we observed among adult HA-MRSA
infections per hospital admission (adj.p=0.011), in which the
second two quarters did not differ from the first two quarters,
1.00x (95% CI 0.89x–1.12x, adj.p=0.97).
Discussion
Seasonality of staphylococcal infections is not noted in many
textbook chapters or review articles. Nevertheless, several
investigators have demonstrated seasonal variation in S. aureus
infections, particularly skin infections, with a preponderance of
infections during the summer and autumn (Tables 1 and 2). As
noted in Tables 1 and 2, seasonal variability has been observed in
pediatric and adult patients in temperate and tropical climates. We
found a two to three-fold increased incidence of MRSA infections
in pediatric patients during the second two quarters over the last
decade. A lesser degree of seasonal variation was observed in adult
CA-MRSA infections. It is difficult to explain the seasonality of
pediatric HA-MRSA infections; however, we suspect that many of
these patients were colonized with MRSA at the time of
hospitalization and infections developed while hospitalized. Since
90% of pediatric hospital visits in Rhode Island are at our hospital,
our data represents the vast majority of pediatric MRSA infections
seen at local hospitals.
We believe that it is the sequence of 3
rd and 4
th quarters which
is important in demonstrating the peak in MRSA infections in
temperate regions rather than just the warmest quarter of the year.
We reviewed meteorologic data for Rhode Island during the
decade of our study period and found that the 2
nd quarter was
warmer, on average, than the 4
th quarter. Thus, we believe that it
is the sequence of 3
rd and 4
th quarters that is important and not
the 3
rd quarter in isolation. We previously demonstrated
transmission of an identical MRSA pulsotype in a large extended
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17925family living in different homes over 2–4 weeks [26]. One study
found a correlation between impetigo and the mean ambient
temperature during the previous month [r=0?55; p=0?001]; 3).
Another study demonstrated a 1–2 month lag between peak
temperature and peak incidence of impetigo in children and this
was ascribed to more insect bites during peak temperatures [21].
Thus, an increased incidence of infection in autumn (4
th quarter),
may reflect a lag between Staphylococcal colonization and
Figure 1. Community-associated MRSA infections along with the model predictions and 95% confidence intervals.
doi:10.1371/journal.pone.0017925.g001
Figure 2. Hospital-associated MRSA infections along with the model predictions and 95% confidence intervals.
doi:10.1371/journal.pone.0017925.g002
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PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17925Table 1. Seasonality and Staphylococcus aureus Mixed Infections, Bacteremia, and Upper Extremity Infections.
Type of Infection Age Locale Seasonality Author
CA
*-MRSA
{ (USA 300 & USA
400 strains) infections
All Iowa Peak incidence: Summer (47% of cases
occurred Jun 21-Sep 22; p,0?001)
[1]
CA-MRSA severe infections All Georgia Peak incidence: Summer (,34% of cases




Adult Georgia Peak incidence: Summer (, 41% of cases occurred
Jul-Sep; ,54% of cases occurred Jul-Oct)
[6]
CA- and HA
{-S. aureus infections All Scotland Peak incidence: ‘Spring seasonal variation of MRSA’
was observed but not for MSSA
1
[7]
CA- and HA-S. aureus infections
requiring hospitalization
Adult Maryland Peak incidence: Jul-Sep (IRR 1?04; p=0?5) [4]
CA-S. aureus infections Pediatric Texas Monthly peak incidence: 2002 =Jul; 2003=Aug; 2004=May [8]
CA-S. aureus infections Pediatric Greece Peak incidence: Summer (72% of cases occurred Jul-Sep) [9]
CA-S. aureus bacteremia All Connecticut Peak incidence: Jul-Sep (RR 1?0; p=non-significant) [10]
CA-S. aureus bacteremia Adult Taiwan Peak incidence: ‘Late autumn and early winter’
(26% of cases occurred Jul-Sep; 42% of cases occurred Jul-Oct)
[11]
S. aureus bacteremia All Massachusetts Peak incidence: ‘There was no peak of incidence at
any season of the year’
[12]
S. aureus pneumonia and
secondary bacteremia
All Maryland Peak incidence: Summer and winter (30% of cases
occurred May-June; 30% of cases occurred Nov-Dec)
[13]
Upper extremity (PVL gene
positive) S. aureus infections
All Greece Peak incidence: Summer (56% of cases occurred Jun-Aug) [14]
*CA = Community-associated;
{MRSA = Methicillin-resistant S. aureus;
{HA = Hospital-associated;
1MSSA = Methicillin-susceptible S. aureus.
doi:10.1371/journal.pone.0017925.t001
Table 2. Seasonality and Staphylococcus aureus Skin Infections.
Type of Infection Age Locale Seasonality Author
CA
*-associated S. aureus ‘boil infections’ All Nigeria Peak incidence: 33% of cases occurred during
warmest recorded months (Jan–Mar)
[15]
CA-associated pyoderma All India Peak incidence: Summer (40% of cases occurred Jun–Aug) [16]
CA-associated pyoderma All Malawi Peak incidence: Summer (Dec–Apr) [17]
CA-associated pyoderma Pediatric India Peak incidence: 68% of cases ‘reported during
the hot and humid months of Jun–Sep’
[18]
Dermatitis cruris pustulosis exacerbation
(87% culture-positive for S. aureus)
All India Peak incidence: Summer (87% of cases) [19]
Impetigo Pediatric Nether-lands Peak incidence in 1987 & 2001: Summer (‘incidence




Peak incidence: ‘Late Summer’ (,37% of cases Jul–Sep;
seasonal effect [p=0?02]; correlation between impetigo and




Peak incidence: Autumn (Oct peak in 4 of 5 years studied);
,1–2 months after the month with the highest average temperature
[21]
Impetigo Pediatric Alabama Peak Incidence: Summer (33% of cases occurred in Aug;
monitored Jul–Jan rather than the calendar year)
[22]
Impetigo Pediatric Australia Peak incidence: 79% of cases occurred in summer and autumn [23]
Impetigo Pediatric Pakistan Peak incidence: Summer (2–3 fold increased incidence/100
person-wks of impetigo in Jul compared with May, Sep, or Oct)
[24]
Impetigo bullosa due to fusidic
acid-resistant S. aureus
Pediatric Norway Peak incidence: ‘Marked seasonal fluctuation with the highest
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respiratory infections in autumn, possibly reflecting transmission in
more confined settings such as schools, may add to greater S. aureus
transmission and subsequent infection during this time [27].
Hydration of the stratum corneum of the skin is an important in
promoting microbial growth [28]. Hydration would be maximized
when high temperatures promote sweat production and in high
relative humidity. The presence of both factors may be critically
important in providing the environmental conditions that facilitate
heavy growth of S. aureus on skin [16]. Nevertheless, one
investigator found an inverse correlation between humidity and
S. aureus skin infections [15]. Some investigators did not observe
any significant seasonality of S. aureus infections [4,10,12]. Since
many reports of seasonality of S. aureus infections involve skin
infections, it may be that these investigators had fewer such
infections in their patient population thus masking the effect.
Grassley and Fraser [29] describe variables that explain
seasonality of infectious diseases: pathogen survival outside the
host; host behavior; host immune function; and abundance of
vectors and non-human hosts. There is a correlation between the
quantity of S. aureus in the nares and on clothing [30] and a
correlation between the quantity of S. aureus in the nares, on skin,
and the quantity of S. aureus in the surrounding air [30–32].
Increased S. aureus transmission during the summer months may
reflect a greater density of this microbe on the skin, nares, throat,
and/or perineum during warmer, and often more humid
conditions [28], it may reflect other environmental conditions
conducive to disease spread, or both. Some authors have not
observed seasonal variation in S. aureus nasopharyngeal carriage
[33–35] but these studies may have been underpowered to find
such a difference and they did not assess colonization of other
body sites.
It is hoped that the current study will prompt further
investigation into the seasonality of S. aureus infections to better
understand the biologic basis for this observation.
Methods
We collected microbiologic data on all clinical (i.e., non-
surveillance) MRSA isolates submitted to our hospital microbiol-
ogy laboratory between January 2001 and March 2010. MRSA
isolates were identified using standard microbiologic methods. We
also determined the number of visits to our adult and pediatric
emergency departments (ED) during this time. We defined CA-
MRSA as isolates obtained within 48 hours of hospitalization and
HA-MRSA based on isolates obtained after 48 hours of
hospitalization, or for surgical wound infections, those who had
their procedure within the prior 30 days.
Quarterly CA-MRSA and HA-MRSA infection counts were
modeled using Poisson regressions, offset with the log number of
ED visits or log number of admissions with lengths of stay of three
or more days, respectively, to adjust for changes in the number of
patients seen. For CA-MRSA infections, the log number of ED
visits for each quarter was used as an offset variable, making the
prediction rates per ED visit. Models included effects for ED visits
(pediatric vs. adult), categorical year, categorical quarter, and the
interactions between ED and year, and ED and quarter. For HA-
MRSA infections, the log number of hospital admissions with
lengths of stay of three or more days for each quarter was used as
an offset variable, making the prediction rates hospital admission.
Models included effects for hospital admission of three or more
days (pediatric vs. adult), categorical year, categorical quarter, and
the interactions between hospital admission and year, and hospital
admission and quarter. Models and hypothesis tests were adjusted
for slight overdispersion based on the Pearson Chi-Square.
Complex comparisons were used to test whether quarters 1 and
2 were significantly different from quarters 3 and 4 within each
(i.e., adult or pediatric) ED visit or hospital admission and to test
for a difference between ED visit or hospital admission in the size
of these effects. Alpha was maintained at 0.05 across all three
hypothesis tests using the Holm test (alpha per comparison =
0.0167). This study was approved by the Rhode Island Hospital
Institutional Review Board. Informed consent was not obtained as
patient-specific data is not reported and data had already been
abstracted in our infection control software program.
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